CRVO Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
-100.0%
8.7K
-97.3%
322.6K
-81.6%
1.8M
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
-100.0%
8.7K
-97.3%
322.6K
-81.6%
1.8M
Operating Expenses
6.7M
-17.7%
8.1M
-2.8%
8.3M
-0.3%
8.4M
-0.1%
8.4M
R&D
4.3M
-15.8%
5.1M
-11.9%
5.8M
-3.5%
6.0M
+18.2%
5.1M
SG&A
2.4M
-20.8%
3.0M
+18.5%
2.5M
+7.9%
2.3M
-28.8%
3.3M
Operating Income
-6678551
+17.7%
-8110524
+2.7%
-8331519
-3.6%
-8044199
-21.6%
-6616275
EBITDA
-6678551
+17.7%
-8110524
+2.7%
-8331519
-3.6%
-8044199
-21.6%
-6616275
Net Income
-6571656
+17.5%
-7964158
+1.5%
-8087290
-4.7%
-7726639
-23.5%
-6258404
EPS (Basic)
$-0.64
+25.6%
$-0.86
+1.1%
$-0.87
-3.6%
$-0.84
-20.0%
$-0.70
EPS (Diluted)
$-0.64
+25.6%
$-0.86
+1.1%
$-0.87
-3.6%
$-0.84
-20.0%
$-0.70
Shares (Diluted)
10.2M
+10.7%
9.3M
-0.0%
9.3M
+0.1%
9.3M
+3.4%
9.0M
CervoMed (CRVO) โ€” Financials